Search Results

K-Ras(G12C) Inhibitor 6 100 mg  | 100.00%

TargetMol

K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.

More Information Supplier Page

K-Ras(G12C) Inhibitor 6 10 mg  | 100.00%

TargetMol

K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.

More Information Supplier Page

K-Ras(G12C) Inhibitor 6 25 mg  | 100.00%

TargetMol

K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.

More Information Supplier Page

K-Ras(G12C) Inhibitor 6 5 mg  | 100.00%

TargetMol

K-Ras(G12C) inhibitor 6 is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein when used at 10 μM for 24 hours in vitro.

More Information Supplier Page

(E)-Methyl 4-coumarate 100 mg  | 99.59%

TargetMol

(E)-Methyl 4-coumarate (OMpCA) is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of methyl 3-phenylprop-2-enoate.

More Information Supplier Page

Isosilybin 10 mg  | 100.00%

TargetMol

Isosilybin and Silybin might be suitable candidates to design potent PXR antagonists to prevent drug-drug interactions via CYP3A4 in cancer patients.

More Information Supplier Page

Isosilybin 5 mg  | 100.00%

TargetMol

Isosilybin and Silybin might be suitable candidates to design potent PXR antagonists to prevent drug-drug interactions via CYP3A4 in cancer patients.

More Information Supplier Page

BTZ043 5 mg  | 99.69%

TargetMol

BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.

More Information Supplier Page

BTZ043 50 mg  | 99.69%

TargetMol

BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.

More Information Supplier Page

BTZ043 10 mg  | 99.69%

TargetMol

BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.

More Information Supplier Page